Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

Journal: Nature Medicine

Published: 2018-11-12

DOI: 10.1038/s41591-018-0238-9

Affiliations: 14

Authors: 25

Go to article
Institutions FC
Department of Genomic Medicine, MD Anderson Cancer Center, United States of America (USA) 0.18
Department of Gastroenterology, Hepatology and Nutrition, MD Anderson Cancer Center, United States of America (USA) 0.16
Department of Surgical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.10
Department of Pathology, MD Anderson Cancer Center, United States of America (USA) 0.07
Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.07
Division of Cancer Medicine, MD Anderson Cancer Center, United States of America (USA) 0.07
Center for Infectious Diseases (CID), UTHealth, United States of America (USA) 0.06
Department of Translational Molecular Pathology, MD Anderson Cancer Center, United States of America (USA) 0.05
Division of Pathology and Laboratory Medicine, MD Anderson Cancer Center, United States of America (USA) 0.05
Department of Immunology, MD Anderson Cancer Center, United States of America (USA) 0.05
Division of Basic Science Research, MD Anderson Cancer Center, United States of America (USA) 0.05
Margaret M. and Albert B. Alkek Department of Medicine, BCM, United States of America (USA) 0.04
Kelsey Research Foundation, United States of America (USA) 0.02
Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, United States of America (USA) 0.02

Return